These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33726636)

  • 1. Comparing the EQ-5D-3L anxiety or depression domain to the Hospital Anxiety and Depression Scale to identify anxiety or depression after stroke.
    Thayabaranathan T; Andrew NE; Stolwyk R; Lannin NA; Cadilhac DA
    Top Stroke Rehabil; 2022 Mar; 29(2):146-155. PubMed ID: 33726636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
    Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
    Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings.
    Short H; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2021 Mar; 19(1):96. PubMed ID: 33741011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
    Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the Hospital Anxiety and Depression Scale 3 months after acute lung injury.
    Jutte JE; Needham DM; Pfoh ER; Bienvenu OJ
    J Crit Care; 2015 Aug; 30(4):793-8. PubMed ID: 25981443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D.
    Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C
    Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of EQ-5D-5L in stroke.
    Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the EQ-5D-3L in South Australia: a multi-method non-preference-based validation study.
    Zakershahrak M; Ribeiro Santiago PH; Sethi S; Haag D; Jamieson L; Brennan D
    Curr Med Res Opin; 2022 May; 38(5):673-685. PubMed ID: 35060425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of in-hospital depression and anxiety symptoms following stroke with 3 months- depression, anxiety and functional outcome.
    Redmond C; Bushnell C; Duncan P; D'Agostino R; Ambrosius WT; Bishop L; Gesell S; Prvu-Bettger J; El Husseini N
    J Clin Neurosci; 2022 Apr; 98():133-136. PubMed ID: 35180502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-Day Test-Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD.
    Hansen H; Beyer N; Frølich A; Godtfredsen N; Bieler T
    Patient Relat Outcome Meas; 2021; 12():117-128. PubMed ID: 34104024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
    Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent validity of the EQ-5D-3L in a randomized-controlled trial of the Housing First model.
    Kozloff N; Pinto AD; Stergiopoulos V; Hwang SW; O'Campo P; Bayoumi AM
    BMC Health Serv Res; 2019 Jul; 19(1):482. PubMed ID: 31300051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
    Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
    Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population.
    Shafie AA; Chhabra IK; Hui Yi JW; Mohammed NS; Ibrahim HM
    Value Health Reg Issues; 2021 May; 24():47-56. PubMed ID: 33508751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the EQ-5D to HADS-identified anxiety and depression.
    Whynes DK;
    J Eval Clin Pract; 2009 Oct; 15(5):820-5. PubMed ID: 19811595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.